Derniers essais

EudraCT Number: 2005-000704-14

Sponsor Protocol Number: S241-GB-07

Start Date:

Sponsor Name: Stiefel Laboratories International Division

Full Title: Human 96 Hour Repeat Open Application Test for Assessment of Skin Irritation

Medical condition: Not applicable (Healthy Volunteer Study)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2014-003882-10

Sponsor Protocol Number: 2014_21

Start Date:

Sponsor Name: CHRU de Lille

Full Title: Evaluation of the effectiveness of a treatment involving one (or several ) antibiotic (s) with 14-day tobramycin ( Nebcine® ) by intravenous injection versus the same antibiotic treatment (s ) asso...

Medical condition: mucoviscidosis or cystic fibrosis

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.0	100000004862	10068288	Cystic fibrosis pulmonary exacerbation	LLT

Population Age: Children, Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2018-002562-40

Sponsor Protocol Number: 16-021

Start Date:

Sponsor Name: Portola Pharma UK Ltd

Full Title: A phase 1, open-label, single dose, non-randomized study to evaluate pharmacokinetics, pharmacodynamics, and safety of Betrixaban in pediatric patients.

Medical condition: Pediatric patients who are assessed to be at risk for Venous thromboembolism (VTE) but does not require immediate anticoagulant therapy, for example: a. Has previous thrombosis and completed a cour...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10042613 - Surgical and medical procedures	10053468	Anticoagulant therapy	PT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2011-002213-12

Sponsor Protocol Number: I10 005

Start Date:

Sponsor Name: CHU de Limoges

Full Title: Paracetamol and setrons : drug interactions in the management of pain after tonsillectomy in children

Medical condition: Pain

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.0	10022117 - Injury, poisoning and procedural complications	10049749	Post procedural pain	LLT
	14.0	10022117 - Injury, poisoning and procedural complications	10064882	Procedural pain	PT

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2021-003768-29

Sponsor Protocol Number: DAY101-102

Start Date:

Sponsor Name: Day One Biopharmaceuticals, Inc. (Day One)

Full Title: A Phase 1b/2, Open Label Study of DAY101 Monotherapy or Combination with Other Therapies for Patients with Recurrent, Progressive, or Refractory Solid Tumors Harboring MAPK Pathway Aberrations

Medical condition: Recurrent, Progressive, or Refractory Solid Tumors Harboring MAPK Pathway Aberrations

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: BE (Ongoing) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-001795-34

Sponsor Protocol Number: CL-N-HTX-Paed-II/10/20

Start Date:

Sponsor Name: Dr. Franz Köhler Chemie GmbH

Full Title: A prospective randomized single blind multicenter phase II study of organ perfusion with Custodiol-N compared with Custodiol in heart transplantation in children

Medical condition: Preservation of hearts prior to heart transplantation in children

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10042613 - Surgical and medical procedures	10019314	Heart transplant	PT

Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2007-005294-60

Sponsor Protocol Number: CRAD001C24114

Start Date:

Sponsor Name: Novartis Pharma GmbH

Full Title: Multicenter, triple-arm, single-stage, phase II trial to determine the preliminary efficacy and safety of RAD001 in patients with histological evidence of progressive or metastatic bone or soft tis...

Medical condition: histological evidence of progressive or metastatic bone or soft tissue sarcomas

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10039494	Sarcoma NOS	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2015-004526-33

Sponsor Protocol Number: PDARCT1

Start Date:

Sponsor Name: Royal College of Surgeons in Ireland

Full Title: A Randomised Controlled Trial of Early Targeted Patent Ductus Arteriosus Treatment Using a Risk Based Severity Score

Medical condition: Patent Ductus Arteriosus

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.1	10010331 - Congenital, familial and genetic disorders	10034130	Patent ductus arteriosus	PT

Population Age: Preterm newborn infants, Newborns, Under 18

Gender: Male, Female

Trial protocol: IE (Completed)

Trial results: (No results available)

EudraCT Number: 2011-004417-16

Sponsor Protocol Number: 5022LC

Start Date:

Sponsor Name: St. Elisabeth Hospital

Full Title: CEFTRIAXONE NEONATAL THERAPY: A RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE EFFECT OF CEFTRIAXONE ON HYPERBILIRUBINEMIA

Medical condition: Hyperbilirubinemia

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Preterm newborn infants, Newborns, Under 18

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2016-002705-19

Sponsor Protocol Number: OMPeR

Start Date:

Sponsor Name: FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO

Full Title: A phase IV, randomized, controlled, double-blind study on efficacy and safety of OM-85 in children with recurrent respiratory tract infections

Medical condition: Recurrent Respiratory Tract Infection

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	100000004862	10039249	RTI	LLT

Population Age: Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

Derniers essais

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue